I Sens Inc
KOSDAQ:099190
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
I Sens Inc
Accrued Liabilities
I Sens Inc
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Accrued Liabilities
₩4.5B
|
CAGR 3-Years
30%
|
CAGR 5-Years
24%
|
CAGR 10-Years
64%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Accrued Liabilities
₩7.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Accrued Liabilities
₩183m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Accrued Liabilities
₩1.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Accrued Liabilities
₩241.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
NextBioMedical Co Ltd
KOSDAQ:389650
|
Accrued Liabilities
₩126.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
I Sens Inc
Glance View
i-SENS, Inc. engages in development and manufacture of medical, environmental, industrial sensors. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-01-30. The Company’s products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The firm distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.
See Also
What is I Sens Inc's Accrued Liabilities?
Accrued Liabilities
4.5B
KRW
Based on the financial report for Dec 31, 2025, I Sens Inc's Accrued Liabilities amounts to 4.5B KRW.
What is I Sens Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
64%
Over the last year, the Accrued Liabilities growth was -12%. The average annual Accrued Liabilities growth rates for I Sens Inc have been 30% over the past three years , 24% over the past five years , and 64% over the past ten years .
